Skip to content

Comparison of analgesic effectiveness of transforaminal epidural steroid injection versus steroid with ketamine in patients with lower back pain

Comparison of analgesic efficacy of transforaminal epidural steroid versus steroid with ketamine in patients with lumbosacral radiculopathy - A randomized controlled trial - nil

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068775
Enrollment
64
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

Intervention1: Transforaminal epidural steroid plus ketamine (group SK): In patients with lumbosacral radiculopathy we will give transforaminal epidural injection with steroid plus ketamine. In this g

Sponsors

Jawaharlal Institute of Postgraduate Medical education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1-2 patients with chronic low back pain, patients with no symptomatic relief from conservative treatment

Exclusion criteria

Exclusion criteria: Patients with spinal cord deformities, previous history of spine surgery, uncontrolled Diabetes, Hypertension, B/L side pain, History of allergy to local anaesthetics, Bleeding disorders, Psychiatric disorders, Pregnancy/lactation

Design outcomes

Primary

MeasureTime frame
To compare the analgesic efficacy in both the groups using Visual Analogue scale(VAS) score at 2 weeksTimepoint: 2 weeks

Secondary

MeasureTime frame
Any adverse eventTimepoint: within 3 months study duration;Medication Quantification Scale(MQS)Timepoint: 24 hr, 2 week, 1st month, 2nd month, 3rd month;Oswestry Disability Index (ODI)Timepoint: 24 hr, 2 week, 1st month, 2nd month, 3rd month;Requirement of repeat block in both the groups during three month periodTimepoint: 3 month;Total duration of analgesiaTimepoint: 3 month

Countries

India

Contacts

Public ContactDr S Adinarayanan

Jawaharlal Institute of Postgraduate Medical Education and Research

adinarayanans@gmail.com9442396762

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026